KOS Revenue, Valuation, Funding & Investors

Genomma Lab Internacional is a Mexican consumer-health company that develops, markets and distributes over-the-counter medicines and personal-care products. Its portfolio includes cold and cough treatments, dermatology products, pain relief, gastrointestinal medicines, hair care, skin care and nutritional beverages. Genomma owns brands such as Tío Nacho, Cicatricure, Next, Tukol, Suerox and XL-3 and sells them through pharmacies, supermarkets and other retailers. The company operates across Mexico, the United States and numerous Latin American markets, using advertising and broad retail distribution to build consumer brands. It manufactures products internally and through third parties and expands through new products and brand acquisitions. Genomma has traded publicly in Mexico since 2008.

Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

PT Tempo Scan Pacific Tbk operates in the pharmaceutical business in Indonesia. It is engaged in the production of tablet/caplets, effervescent powders, liquid/syrup, cream and ointment, and capsule dosage forms, and markets body care products. It operates through the following segments: The Pharmaceuticals segment, the Consumer Products and Cosmetics segment, and the Distribution Services segment. The company caters to both Indonesian and international markets.

Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.

Jamieson Wellness Inc is engaged in the manufacturing, development, distribution, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Youtheory, Progressive, Precision, Smart Solutions, and Iron Vegan. Geographically, the majority of its revenue is derived from the domestic market.

Zydus Wellness Ltd is engaged in the production and distribution of health and wellness products. It has several brands, including Everyuth, Sugar-Free, and Nutralite. The company offers specialty skincare products under the brand Everyuth Naturals. Zydus's sugar-free product portfolio, a sugar substitute category, consists of Sugar-Free gold for tabletop usage and Sugar-Free Natura for culinary usage. The firm also offers healthy foods, including Nutralite, a healthy butter substitute. Company brands includes: Complan, Sugar Free, Glucon-D, Everyuth, Nycil, Nutralite, and Others.

PharmaNutra is an Italian nutraceutical and medical device company based in Pisa, founded in 2003 and led by chairman Andrea Lacorte and vice chairman Roberto Lacorte. It develops iron and mineral supplements, above all the SiderAL brand built on patented Sucrosomial technology, and also sells muscle and joint products under the Cetilar brand. In Italy a network of more than 160 scientific sales representatives serves physicians and pharmacies, while sales abroad run through 47 partner companies in 70 countries. The shares are listed on Euronext STAR Milan under the ticker PHN. In 2022 the company bought Akern, a maker of body composition analysis instruments, and in 2024 it merged its subsidiaries Junia Pharma and Alesco into the parent. Consolidated revenues were EUR 116.9 million and EBITDA EUR 31.0 million in 2024.

FDC makes and sells pharmaceutical formulations, including oral rehydration products under the Electral brand, ophthalmic products and anti-infectives, in India and export markets. The company is headquartered in Mumbai.

Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.

Indian consumer healthcare arm of a global drug group, selling over-the-counter and consumer health brands such as Allegra, Combiflam, Avil and Enterogermina through pharmacies. Based in Mumbai.

Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. The company manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, acids, and xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.

Morepen Laboratories makes active pharmaceutical ingredients, finished dosage forms and branded consumer health products. Key APIs include loratadine and montelukast, and it sells glucometers and other home-care devices under the Dr Morepen brand. Customers are generic drug makers and retail consumers in India and export markets. It is headquartered in New Delhi.

Jubilant Ingrevia makes life science chemicals, nutrition and animal ingredients, and specialty intermediates. Products include pyridine and picolines, acetyl chemicals, vitamin B3 and agri and pharma intermediates. Customers are pharma, agrochemical, nutrition and consumer companies in India and abroad. It was demerged from Jubilant Life Sciences and is headquartered in Noida.

Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.

Zespri is a New Zealand-headquartered marketer of kiwifruit, representing 3,300 growers exporting 180 million trays annually to 55 countries. The cooperative sells green, gold, organic, and SunGold varieties, generating over NZ$3 billion in revenue. Tauranga-based Zespri manages supply chain logistics, R&D for new cultivars like RubyRed, and sustainability programs including carbon-neutral goals by 2025. Key markets include China, Europe, and North America, with innovations in post-harvest technology extending shelf life.